Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Immune system changes may contribute to female pattern hair loss.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

The patient had a severe itchy rash and hair loss in the armpits.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

ILC1-like cells can independently cause alopecia areata.

FFA patients have fewer melanocytes and thinner skin compared to others.

BTNL2 helps protect hair follicles from immune attacks.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Human hair follicles have their own thyroid hormone system.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Autoimmune markers may help diagnose and manage PCOS.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Combination therapies may be more effective for treating Folliculitis Decalvans than antibiotics alone.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.